Simplify Asset Management »

United Therapeutics Corporation shares owned by Simplify Asset Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.4M 20k 419.21
2022-12-31 $364k 1.3k 278.09
2022-09-30 $1.7M 7.9k 209.38
2022-06-30 $1.3M 5.4k 235.71
2022-03-31 $780k 4.4k 179.31
2021-12-31 $469k 2.2k 215.93

More positions owned by Simplify Asset Management

Simplify Exchange Traded Fun Government Money
Ishares Tr Core S&p500 Etf (IVV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Ishares Tr Core Us Aggbd Et (AGG)
Simplify Exchange Traded Fun Multi Qis Altern (QIS)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Simplify Exchange Traded Fun Us Eqt Pls Upsid (SPUC)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Simplify Exchange Traded Fun Natl Muni Bd Etf (NMB)
Simplify Exchange Traded Fun Next Intangible (NXTI)
Simplify Exchange Traded Fun Target 15 Distri (XV)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Simplify Exchange Traded Fun Currency Strateg (FOXY)

View all positions for Simplify Asset Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation